Shuttle Pharmaceuticals Holdings (SHPH) Change in Interest Receivables (2023 - 2024)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Change in Interest Receivables came in at -$4.0 in Q4 2024, down 100.16% year-on-year from $2466.0 in Q1 2024, and up 99.94% quarter-over-quarter from -$7222.0 in Q3 2024.
Shuttle Pharmaceuticals Holdings (SHPH) Change in Interest Receivables (2023 - 2024) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Change in Interest Receivables history runs 2 years deep, the most recent figure standing at -$4.0 for Q4 2024.
- On a quarterly basis, Change in Interest Receivables fell 100.16% year-over-year to -$4.0 in Q4 2024; TTM through Dec 2024 was -$14901.0, a 200.0% decrease from a year earlier, with the FY2024 full-year figure at -$14901.0, down 200.0% from the prior year.
- Change in Interest Receivables improved to -$4.0 in Q4 2024 per SHPH's latest filing, from -$7222.0 in the prior quarter.
- Across five years, Change in Interest Receivables topped out at $7023.0 in Q1 2023 and bottomed at -$7222.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -4.00 |
| Sep 30, 2024 | -7,222.00 |
| Jun 30, 2024 | -4,738.00 |
| Mar 31, 2024 | -2,937.00 |
| Dec 31, 2023 | 2,466.00 |
| Sep 30, 2023 | 5,485.00 |
| Jun 30, 2023 | -73.00 |
| Mar 31, 2023 | 7,023.00 |